HCA Healthcare
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade HCA Healthcare 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About HCA
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
CEOSamuel N. Hazen
CEOSamuel N. Hazen
Employees316,000
Employees316,000
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded1968
Founded1968
Employees316,000
Employees316,000
HCA Key Statistics
Market cap83.88B
Market cap83.88B
Price-Earnings ratio15.15
Price-Earnings ratio15.15
Dividend yield0.81%
Dividend yield0.81%
Average volume1.89M
Average volume1.89M
High today—
High today—
Low today—
Low today—
Open price$336.56
Open price$336.56
Volume1.63K
Volume1.63K
52 Week high$417.14
52 Week high$417.14
52 Week low$289.98
52 Week low$289.98
HCA News
TipRanks 2h
HCA Healthcare downgraded to Neutral from Outperform at BairdBaird downgraded HCA Healthcare (HCA) to Neutral from Outperform with a price target of $336, down from $396. The firm sees minimal incremental buyers of stocks...
Simply Wall St 4d
HCA Healthcare Collaborates On Studies To Combat Antibiotic Resistance Nationwiderecently presented significant findings from multi-state studies on antibiotic selection in *JAMA Surgery* and *JAMA Internal Medicine*, with impactful implicat...
Analyst ratings
57%
of 28 ratingsBuy
57.1%
Hold
39.3%
Sell
3.6%